A novel antithrombotic agent. A highly potent and selective, direct FXa inhibitor.Melting Point: As reportedSolubility:As reportedSpecific Rotation: As reported Method for Determining Identity:Proton NMR (DMSO-d6 and Acetone-d6) Spectroscopic and Mass Spectrometric TLC Conditions:As reported Storage and Stability:May be stored at RT for short-term only. Long-term storage is recommended at 4°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.Toxicity and Hazards: All products should be handled by qualified personnel only, trained in laboratory procedures.
